Dergiler / Eurasian Journal of Medical Investigation / 2022 / Cilt: 6 - Sayı: 1

Can Albumin Bilirubin Ratio Predict Survival in Metastatic Gastric Cancer?

Sayfa
106–110
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Studies should be conducted with a more significant number of patient populations to determine the role of ABR in GC

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: This study evaluated the prognostic significance of the new index designed with albumin and bilirubin ratio (ABR) in patients with metastatic gastric cancer (GC).
📊
Temel Bulgular & Veri:Methods: The data of patients with metastatic gastric cancer followed in the medical oncology clinic between February 2012, and May 2020 were retrospectively reviewed.
💡
Sonuç & Katkı:Studies should be conducted with a more significant number of patient populations to determine the role of ABR in GC
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2012 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: This study evaluated the prognostic significance of the new index designed with albumin and bilirubin ratio (ABR) in patients with metastatic gastric cancer (GC). Methods: The data of patients with metastatic gastric cancer followed in the medical oncology clinic between February 2012, and May 2020 were retrospectively reviewed. ABR was defined by dividing the albumin level by the bilirubin level. Results: Overall survival (OS) of all patients was reported as 12.9 months (95% CI, 10.9-14.9). The effect of ABR on survival time was not found statistically significant (p=0.462; p>0.05). Conclusion: This study evaluated the prognostic significance of the new index designed with ABR in patients with metastatic gastric cancer (GC), but no statistically significant result was obtained. Simple, accessible, and inexpensive tests showing recurrence, treatment response, and prognosis of GC are needed. Studies should be conducted with a more significant number of patient populations to determine the role of ABR in GC

🔖

Bu Makaleye Atıf Yap

EKİNCİ, F., ERDOGAN, A. P. (2022). Can Albumin Bilirubin Ratio Predict Survival in Metastatic Gastric Cancer?. Eurasian Journal of Medical Investigation, Cilt: 6 - Sayı: 1, 106–110. https://ajindex.com/articles/508539

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424
  2. Johnston FM, Beckman M. Updates on management of gastric cancer. Curr Oncol Rep 2019;21:67
  3. Song Z, Wu Y, Yang J, Yang D, Fang X. Progress in the treatment of advanced gastric cancer. Tumour Biol 2017;39:1010428317714626
  4. Wu H, Wang W, Tong S, Wu C. Nucleostemin regulates proliferation and migration of gastric cancer and correlates with its malignancy. Int J Clin Exp Med 2015;8:17634–43 5. Matsuoka T, Yashiro M. Biomarkers of gastric cancer: Current topics and future perspective. World J Gastroenterol 2018;24:2818–32
  5. Ekinci F, Erdoğan AP, Dirican A, Göksel G. The effect of neutrophil lymphocyte ratio on prognosis in patients with metastatic renal cell carcinoma. Abant Med J 2021;10:136–41
  6. Greten FR, Grivennikov SI. Inflammation and cancer: Triggers, mechanisms, and consequences. Immunity 2019;51:27–41
  7. Chen XL, Xue L, Wang W, Chen HN, Zhang WH, Liu K, et al. Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study. Oncotarget 2015;6:41370–82
  8. Lin JX, Lin JP, Xie JW, Wang JB, Lu J, Chen QY, et al. Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer. Gastric Cancer 2019;22:403–12
  9. Powell AGMT, Parkinson D, Patel N, Chan D, Christian A, Lewis WG. Prognostic significance of serum inflammatory markers in gastric cancer. J Gastrointest Surg 2018;22:595–605
  10. Lozano J, Arbulú I, Rey-Maquieira J. The greening role of tour operators. Environ Manage 2016;57:49–61
  11. Hara K, Aoyama T, Yamada T, Nakazono M, Nagasawa S, Shimoda Y, et al. The prognostic value of the perioperative systemic inflammation score for patients with advanced gastric cancer. Anticancer Res 2020;40:1503–12
  12. Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approachthe ALBI grade. J Clin Oncol 2015;33:550–8
  13. Wang YY, Zhong JH, Su ZY, Huang JF, Lu SD, Xiang BD, et al. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. Br J Surg 2016;103:725–34
  14. Ma XL, Zhou JY, Gao XH, Tian L, Wu J, Zh